Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
<h4>Background</h4>Development of a competent collateral circulation in established coronary artery disease is cardio-protective. The vascular endothelial growth factor (VEGF) system plays a key role in this process. We investigated the prognostic performance of circulating VEGF-A and th...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0254206 |
| _version_ | 1818401629957783552 |
|---|---|
| author | Barry R Palmer Melinda A Paterson Chris M Frampton Anna P Pilbrow Lorraine Skelton Chris J Pemberton Robert N Doughty Chris J Ellis Richard W Troughton A Mark Richards Vicky A Cameron |
| author_facet | Barry R Palmer Melinda A Paterson Chris M Frampton Anna P Pilbrow Lorraine Skelton Chris J Pemberton Robert N Doughty Chris J Ellis Richard W Troughton A Mark Richards Vicky A Cameron |
| author_sort | Barry R Palmer |
| collection | DOAJ |
| description | <h4>Background</h4>Development of a competent collateral circulation in established coronary artery disease is cardio-protective. The vascular endothelial growth factor (VEGF) system plays a key role in this process. We investigated the prognostic performance of circulating VEGF-A and three genetic variants in the VEGFA gene in a clinical coronary cohort.<h4>Methods and results</h4>The Coronary Disease Cohort Study (CDCS) recruited 2,140 patients, with a diagnosis of acute coronary syndrome (ACS), after admission to Christchurch or Auckland City Hospitals between July 2002 and January 2009. We present data for 1927 patients from the cohort genotyped for three SNPs in the VEGF-A gene, rs699947 (C-2578A), rs2010963 (C405G) and rs3025039 (C936T). Plasma VEGF-A concentrations were assayed in a subgroup (n = 550) of CDCS patients (geometric mean 36.6 [34.7-38.5] pg/ml). VEGF-A levels correlated with patient heart rate at baseline (p = 0.034). None of rs699947, rs3025039, nor rs2010963 genotypes were significantly associated with VEGF-A levels, but rs3025039 genotype was positively associated with collateral vessels perfusion according to the Rentrop classification (p = 0.01) and baseline natriuretic peptide levels (p<0.05). Survival in the CDCS cohort was independently associated with baseline VEGF-A levels and (in males) with rs699947 genotype.<h4>Conclusions</h4>This study is strongly suggestive that VEGF-A levels have value as a prognostic biomarker in coronary heart disease patients and SNPs in VEGF-A deserve further investigation as prognostic markers and indicators of angiogenic potential influencing the formation of collateral circulation. |
| first_indexed | 2024-12-14T07:55:31Z |
| format | Article |
| id | doaj.art-6fa3494f411c4b08af18bcb3f58ba37b |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-14T07:55:31Z |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-6fa3494f411c4b08af18bcb3f58ba37b2022-12-21T23:10:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01167e025420610.1371/journal.pone.0254206Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.Barry R PalmerMelinda A PatersonChris M FramptonAnna P PilbrowLorraine SkeltonChris J PembertonRobert N DoughtyChris J EllisRichard W TroughtonA Mark RichardsVicky A Cameron<h4>Background</h4>Development of a competent collateral circulation in established coronary artery disease is cardio-protective. The vascular endothelial growth factor (VEGF) system plays a key role in this process. We investigated the prognostic performance of circulating VEGF-A and three genetic variants in the VEGFA gene in a clinical coronary cohort.<h4>Methods and results</h4>The Coronary Disease Cohort Study (CDCS) recruited 2,140 patients, with a diagnosis of acute coronary syndrome (ACS), after admission to Christchurch or Auckland City Hospitals between July 2002 and January 2009. We present data for 1927 patients from the cohort genotyped for three SNPs in the VEGF-A gene, rs699947 (C-2578A), rs2010963 (C405G) and rs3025039 (C936T). Plasma VEGF-A concentrations were assayed in a subgroup (n = 550) of CDCS patients (geometric mean 36.6 [34.7-38.5] pg/ml). VEGF-A levels correlated with patient heart rate at baseline (p = 0.034). None of rs699947, rs3025039, nor rs2010963 genotypes were significantly associated with VEGF-A levels, but rs3025039 genotype was positively associated with collateral vessels perfusion according to the Rentrop classification (p = 0.01) and baseline natriuretic peptide levels (p<0.05). Survival in the CDCS cohort was independently associated with baseline VEGF-A levels and (in males) with rs699947 genotype.<h4>Conclusions</h4>This study is strongly suggestive that VEGF-A levels have value as a prognostic biomarker in coronary heart disease patients and SNPs in VEGF-A deserve further investigation as prognostic markers and indicators of angiogenic potential influencing the formation of collateral circulation.https://doi.org/10.1371/journal.pone.0254206 |
| spellingShingle | Barry R Palmer Melinda A Paterson Chris M Frampton Anna P Pilbrow Lorraine Skelton Chris J Pemberton Robert N Doughty Chris J Ellis Richard W Troughton A Mark Richards Vicky A Cameron Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. PLoS ONE |
| title | Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. |
| title_full | Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. |
| title_fullStr | Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. |
| title_full_unstemmed | Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. |
| title_short | Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. |
| title_sort | vascular endothelial growth factor a promoter polymorphisms circulating vegf a and survival in acute coronary syndromes |
| url | https://doi.org/10.1371/journal.pone.0254206 |
| work_keys_str_mv | AT barryrpalmer vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT melindaapaterson vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT chrismframpton vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT annappilbrow vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT lorraineskelton vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT chrisjpemberton vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT robertndoughty vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT chrisjellis vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT richardwtroughton vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT amarkrichards vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes AT vickyacameron vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes |